News & Updates

Tofacitinib demonstrates greater efficacy than placebo at week 12 in patients with ankylosing spondylitis (AS) regardless of their baseline C-reactive protein (CRP) levels, a study has shown.

Patients with a diagnosis of lymphangioleiomyomatosis (LAM) are at higher risk of developing lung cancer, reveals a recent study.

A high mortality risk hounds patients with acute exacerbation (AE) of fibrotic interstitial lung disease (FILD) despite treatment with corticosteroids, reports a study, noting that such risk is similar to that seen in those with AE of idiopathic pulmonary fibrosis (IPF).

Telehealth appropriateness is significantly associated with provider preference, the current and previous encounter modality, and rheumatoid arthritis (RA) disease activity, but not with RA medications, patient demographics, and comorbid noninflammatory causes of joint pain, a study has shown.

In a study assessing the correlation between modifiable lifestyle factors and post-COVID-19 outcomes, the risk of post-COVID-19 multisystem sequelae, death, and hospitalization decreased across healthy lifestyle categories during both the acute and post-acute phases of infection.